Author

Klaudia Farkas 1

1 University of Szeged,Szeged,Hungary

ADVANCES IN OPTIMALIZATION OF THERAPEUTIC DRUG MONITORING USING MUCOSAL TNF EXPRESSION AND ANTI-TNF CONCENTRATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH BIOLOGICALS - PRELIMINARY RESULTS FROM A SINGLE CENTER STUDY

Klaudia Farkas, Gréta Elekes, Diána Kata, Imre Földesi, Tamás Ferenci, Tamara Madacsy, Mariann Rutka, Anita Balint, Renáta Bor, Anna Fabian, Ágnes Milassin, Szilvia Lada, Zoltan Gabor Szepes, Ferenc Nagy, József Maléth, Tamás Molnár

ADVANCES IN OPTIMALIZATION OF THERAPEUTIC DRUG MONITORING USING MUCOSAL TNF EXPRESSION AND ANTI-TNF CONCENTRATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH BIOLOGICALS – PRELIMINARY RESULTS FROM A SINGLE CENTER STUDY

Klaudia Farkas

BIOSIMILAR INFLIXIMAB: EFFICACY AND SAFETY BASED ON INTERIM RESULTS FROM A PROSPECTIVE NATIONWIDE COHORT

Krisztina Barbara Gecse, Klaudia Farkas, Barbara Dorottya Lovasz, János Banai, László Bene, Beata Gasztonyi, Petra Anna Golovics, Tünde Kristóf, Peter L Lakatos, Pal Miheller, Ferenc Nagy, Karoly Palatka, Mária Papp, Árpád V. Patai, Ágnes Szabone Salamon, Tamás Szamosi, Zoltan Gabor Szepes, Gábor Tamás Tóth, Aron Vincze;;

CHANGE IN THE EXPRESSION OF SERPIN E1, A POTENTIAL NEW DISEASE ACTIVITY MARKER, REFLECTS THERAPEUTIC RESPONSE IN INFLAMMATORY BOWEL DISEASE

Boldizsár Jójárt, Viktória Szabó, Arpad Varga, Kata Szántó, Diána Kata, Imre Földesi, Tamás Molnár, József Maléth, Klaudia Farkas

CHANGES OF ADALIMUMAB TROUGH LEVELS CORRELATE WITH BODY COMPOSITION PARAMETERS

Agnes Anna Csontos, Andrea Molnár, Zsolt Piri, Balázs Katona, Klaudia Farkas, Tamás Molnár, Pal Miheller

CHARACTERISTICS OF ANTI-TNF ALPHA THERAPY FOR ULCERATIVE COLITIS BETWEEN 2010-2016 IN HUNGARY

Anita Balint, Klaudia Farkas, Ágnes Milassin, Kata Szántó, Péter Takács, János Gimesi-Országh, Péter Kunovszki, Tamás Szamosi, Tamás Molnár

CLINICAL EFFICACY, DRUG SUSTAINABILITY AND RESULTS FROM THERAPEUTIC DRUG MONITORING IN CROHN'S DISEASE PATIENTS TREATED WITH USTEKINUMAB - 1-YEAR FOLLOW-UP OF A PROSPECTIVE, NATIONWIDE, MULTICENTER COHORT FROM HUNGARY

Lorant Gonczi, Kata Szántó, Klaudia Farkas, Tamás Molnár, Tamás Szamosi, Eszter Schäfer, Petra Anna Golovics, Barbara Dorottya Lovasz, Mark Juhasz, Árpád V. Patai, Aron Vincze, Patrícia Sarlós, Karoly Palatka, Alexandra Farkas, Gábor Tamás Tóth, Peter L Lakatos, Pal Miheller, Ákos Iliás

CLINICAL ROLE, OPTIMAL TIMING AND FREQUENCY OF MEASUREMENT OF SERUM INFLIXIMAB LEVELS AND ANTI-INFLIXIMAB ANTIBODY TITERS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Renáta Bor, Klaudia Farkas, Anita Balint, Ágnes Milassin, Mariann Rutka, Mária Matuz, Ferenc Nagy, Anna Fabian, Zoltan Gabor Szepes, Tamás Molnár

COMPARISON OF THE EFFECTIVENESS AND SAFETY OF THE VEDOLIZUMAB THERAPY USING IN COMBINATION WITH OR WITHOUT CYCLOSPORINE IN ULCERATIVE COLITIS

Tamás Resál, Kata Szántó, Daniella Pigniczki, Mariann Rutka, Renáta Bor, Anna Fabian, Zoltan Gabor Szepes, Klaudia Farkas, Ferenc Nagy, Tamás Molnár

CORRELATION BETWEEN THE CLINICAL, ENDOSCOPIC AND HISTOLOGICAL ACTIVITIES OF ULCERATIVE COLITIS

Ágnes Milassin, Klaudia Farkas, Zoltan Gabor Szepes, Ferenc Nagy, Anita Balint, Renáta Bor, Tibor Wittmann, Tamás Molnár

Item 1 - 10 / 105
1
2 3 4 5 6 7
...
10 11